参考文献/References:
[1] DALBETH N,MERRIMAN T R,STAMP L K.Gout[J].Lancet,2016,388(10055):2039-2052.
[2] LEE J S,KWON O C,OH J S,et al.Clinical features and recurrent attack in gout patients according to serum urate levels during an acute attack[J].Korean J Intern Med,2020,35(1):240-248.
[3] SOS B,SZAMOSI S,BENK? S,et al.Recent advances in gout:pathogenesis,diagnosis,comorbidities,treatment[J].Orv Hetil,2018,159(40):1625-1636.
[4] SUN S S,TIAN L,FENG X D,et al.Application of musculoskeletal ultrasound combined with biomechanics in asymptomatic hyperuricemia and acute phase of gout arthritis[J].Chin J Integr Tradit Western Med Imag,2019,17:262-265.
[5] KHAN M,EVANIEW N,JOHAL H,et al.Arthroscopic management of osteoarthritis[J].J Am Acad Orthop Surg,2016,24(7):e79-e80.
[6] PEREZ-RUIZ F,ATXOTEGI J,HERNANDO I,et al.Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy:a prospective study[J].Arthritis Rheum,2006,55(5):786-790.
[7] TRIOLO P,ROSSI R,ROSSO F,et al.Arthroscopic synovectomy of the knee in rheumatoid arthritis defined by the 2010 ACR/EULAR criteria[J].Knee,2016,23(5):862-866.
[8] TAYLOR W J,FRANSEN J,JANSEN T L,et al.Study for updated gout classification criteria:identification of features to classify gout[J].Arthritis Care Res(Hoboken),2015,67(9):1304-1315.
[9] SMITH E U R,DLAZ-TORNE C,PEREZ-RUIZ F,et al.Epidemiology of gout,an update[J].Best Practice & Research Clinical Rheumatology,2010,24(6):811-827.
[10] RICHETTE P,DOHERTY M,PASCUAL E,et al.2018 updated european league against rheumatism evidence based recommendations for the diagnosis of gout[J].Ann Rheum Dis,2020,79(1):31-38.
[11] MIN H K,KIM H R.Does normouricemic status in acute gouty arthritis really reflect a normal status consider confounders of serum levels of urate[J].Korean J Intern Med,2020,35(1):62-64.
[12] KHANNA P P,GLADUE H S,SINGH M K,et al.Treatment of acute gout:a systematic review[J].Semin Arthritis Rheum,2014,44(1):31-38.
[13] KHANNA D,KHANNA P P,FITZGERALD J D,et al.2012 American college of rheumatology guidelines for management of gout.Part 2:therapy and antiinflammatory prophylaxis of acute gouty arthritis[J].Arthritis Care Res(Hoboken),2012,64(10):1447-1461.
[14] SHOJI A,YAMANAKA H,KAMATANI N.A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis:evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy[J].Arthritis Rheum,2004,51(3):321-325.
[15] LU C C,WEI J C C,CHANG C A,et al.Limited knee-joint range of motion in patients with tophaceous gout improved with medical treatment:a 18-months follow up[J].Front Med,2020,7:74.
[16] 毛晓东,辛晓春,向韵.膝关节镜对改善痛风性膝关节炎患者关节功能的影响评价[J].中国社区医师,2019,35(18):39-40.
[17] 张伟强,李具宝,李帆冰.关节痛风石取出手术对痛风患者血尿酸水平的影响[J].昆明医科大学学报,2017,38(1):61-64.
[18] BECKER M A,MACDONALD P A,HUNT B J,et al.Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy[J].Nucleosides Nucleotides Nucleic Acids,2008,27(6):585-591.
[19] BAIL?N R,GONZ?LEZ SENAC N M,LPEZ M M,et al.Efficacy and safety of a urate lowering regimen in primary gout[J].Nucleosides Nucleotides Nucleic Acids,2014,33(4-6):174-180.
[20] ROGER A.Physiological chemisty of uric acid:solubility,colloid ion-binding properties[J].Biochem Physiol,1979,67:27-34.
[21] 肖颖,张思容,唐志宏,等.膝关节液 pH 值与痛风结晶的形成[J].中国组织工程研究与临床康复,2011,15(26):4857-4859.